• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多参数前列腺 MRI 上检测前列腺癌时,表观扩散系数 (ADC) 图上的目标值用于对扩散加权成像 (DWI) 受限的强度进行分类。

Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.

机构信息

Hospital Israelita Albert Einstein, São Paulo, SP, Brasil.

Ecoar Medicina Diagnostica, Belo Horizonte, MG, Brasil.

出版信息

Int Braz J Urol. 2018 Sep-Oct;44(5):882-891. doi: 10.1590/S1677-5538.IBJU.2018.0038.

DOI:10.1590/S1677-5538.IBJU.2018.0038
PMID:30044597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237531/
Abstract

PURPOSE

To identify objective and subjective criteria on multiparametric prostate MRI that can be helpful for prostate cancer detection.

MATERIALS AND METHODS

Retrospective study, IRB approved, including 122 patients who had suspicious lesion on MRI and who underwent prostate biopsy with ultrasonography (US)/MRI imaging fusion. There were 60 patients with positive biopsies and 62 with negative biopsies. MRI of these patients were randomized and evaluated independently by two blinded radiologists. The following variables were analyzed in each lesion: morphology, contours, T2 signal, diffusion restriction (subjective impression and objective values), hyper-enhancement, contact with transition zone or prostatic contour, prostatic contour retraction, Likert and PIRADS classification.

RESULTS

Apparent diffusion coefficient (ADC) value was the best predictor of positivity for prostate cancer, with mean value of 1.08 (SD 0.20) and 1.09 mm2/sec (SD 0.24) on negative biopsies and 0.81 (SD 0.22) and 0.84 mm2/sec (SD 0.22) on positive biopsies for readers 1 and 2, respectively (p < 0.001 in both analysis). For the others categorical variables evaluated the best AUC for reader 1 was subjective intensity of diffusion restriction (AUC of 0.74) and for reader 2 was hyper-enhancement (AUC of 0.65), all inferior comparing to the value of ADC map. Interobserver agreement ranged from 0.13 to 0.75, poor in most measurements, and good or excellent (kappa > 0.6) only in lesion size and ADC values.

CONCLUSIONS

Diffusion restriction with lower ADC-values is the best parameter to predict cancer on MRI prior to biopsy. Efforts to establish an ADC cutoff value would improve cancer detection, especially for less experience reader.

摘要

目的

确定多参数前列腺 MRI 中有助于前列腺癌检测的客观和主观标准。

材料和方法

回顾性研究,IRB 批准,包括 122 名 MRI 显示可疑病灶并接受超声(US)/MRI 图像融合引导前列腺活检的患者。其中 60 例活检阳性,62 例活检阴性。对这些患者的 MRI 进行随机分组,由两名盲法放射科医生独立评估。对每个病灶进行以下变量分析:形态、轮廓、T2 信号、弥散受限(主观印象和客观值)、高强化、与移行带或前列腺轮廓接触、前列腺轮廓回缩、Likert 和 PIRADS 分类。

结果

表观扩散系数(ADC)值是预测前列腺癌阳性的最佳指标,两位观察者的 ADC 值分别为:阴性活检组的平均 ADC 值为 1.08(0.20)和 1.09mm2/sec(0.24),阳性活检组的平均 ADC 值为 0.81(0.22)和 0.84mm2/sec(0.22)(两种分析均 p < 0.001)。对于其他分类变量,观察者 1 的最佳 AUC 为弥散受限的主观强度(0.74),观察者 2 的最佳 AUC 为高强化(0.65),与 ADC 图的 AUC 相比均较低。观察者间一致性范围为 0.13 至 0.75,在大多数测量中较差,仅在病灶大小和 ADC 值方面为良好或优秀(kappa > 0.6)。

结论

弥散受限的 ADC 值较低是在活检前预测 MRI 上癌症的最佳参数。努力确定 ADC 截断值将提高癌症检测率,尤其是对经验较少的观察者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e531/6237531/bf54d213a3b8/1677-6119-ibju-44-05-0882-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e531/6237531/c4a8cadb76fe/1677-6119-ibju-44-05-0882-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e531/6237531/bf54d213a3b8/1677-6119-ibju-44-05-0882-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e531/6237531/c4a8cadb76fe/1677-6119-ibju-44-05-0882-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e531/6237531/bf54d213a3b8/1677-6119-ibju-44-05-0882-gf02.jpg

相似文献

1
Objective value on Apparent diffusion coefficient (ADC) map to categorize the intensity of diffusion-weighted imaging (DWI) restriction for prostate cancer detection on multiparametric prostate MRI.在多参数前列腺 MRI 上检测前列腺癌时,表观扩散系数 (ADC) 图上的目标值用于对扩散加权成像 (DWI) 受限的强度进行分类。
Int Braz J Urol. 2018 Sep-Oct;44(5):882-891. doi: 10.1590/S1677-5538.IBJU.2018.0038.
2
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
3
Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.传统视野与缩小视野的前列腺扩散加权成像:图像质量比较、与组织学的相关性及阅片者间一致性
Magn Reson Imaging. 2018 Apr;47:67-76. doi: 10.1016/j.mri.2017.10.011. Epub 2017 Dec 5.
4
Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.多参数 MRI 测量的前列腺指数病变大小和平均表观扩散系数值的可重复性:与标本全切片的相关性。
AJR Am J Roentgenol. 2018 Oct;211(4):783-788. doi: 10.2214/AJR.17.19172. Epub 2018 Aug 30.
5
Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.动态对比增强磁共振成像和扩散加权磁共振成像对前列腺影像报告和数据系统(PI-RADS)检测临床显著性前列腺癌的贡献
Radiology. 2023 Jan;306(1):186-199. doi: 10.1148/radiol.212692. Epub 2022 Aug 16.
6
Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.扩散峰度成像与标准扩散成像在周围区前列腺癌检测及分级中的评估
Invest Radiol. 2015 Aug;50(8):483-9. doi: 10.1097/RLI.0000000000000155.
7
MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.正常前列腺外周带的MRI特征:年龄与T2WI、DWI及DCE序列上信号异质性的关系
Eur Radiol. 2021 Jul;31(7):4908-4917. doi: 10.1007/s00330-020-07545-7. Epub 2021 Jan 4.
8
Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.多参数磁共振成像用于检测放射性复发前列腺癌:表观扩散系数图和动态对比增强图像的附加价值
Prostate Cancer Prostatic Dis. 2015 Jun;18(2):128-36. doi: 10.1038/pcan.2014.55. Epub 2015 Feb 3.
9
Objective Value of the Apparent Diffusion Coefficient (ADC) Map from Ultrahigh b-value Diffusion-weighted Imaging (DWI) in 3T MRI could be a Non-invasive Specific Biomarker for Prostate Cancer.目的 3T 磁共振成像(MRI)中超高 b 值扩散加权成像(DWI)的表观扩散系数(ADC)图的数值可能是前列腺癌的一种非侵入性特异性生物标志物。
Curr Med Imaging. 2023 Jul 18. doi: 10.2174/1573405620666230718141917.
10
Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.移行区前列腺癌:重新探讨 3T 多参数 MRI 的作用。
AJR Am J Roentgenol. 2015 Mar;204(3):W266-72. doi: 10.2214/AJR.14.12955.

引用本文的文献

1
Quantitative ADC: An Additional Tool in the Evaluation of Prostate Cancer?定量表观扩散系数:前列腺癌评估中的一种额外工具?
J Pers Med. 2023 Sep 15;13(9):1378. doi: 10.3390/jpm13091378.
2
Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Cerebral Venous Thrombosis : A Meta-Analysis.磁共振扩散加权成像在脑静脉血栓形成诊断中的应用:一项Meta分析
J Korean Neurosurg Soc. 2021 May;64(3):418-426. doi: 10.3340/jkns.2020.0247. Epub 2021 Apr 30.

本文引用的文献

1
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.多参数 MRI 和 TRUS 活检在前列腺癌(PROMIS)中的诊断准确性:一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
2
Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker?正常肝脏的表观扩散系数标准化:作为一种新的生物标志物,它能否提高不同磁共振扫描仪上扩散加权成像的可重复性?
Medicine (Baltimore). 2017 Jan;96(3):e5910. doi: 10.1097/MD.0000000000005910.
3
Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
PI-RADS 版本 2 决策规则的拟议调整:对前列腺癌检测的影响。
Radiology. 2017 Apr;283(1):119-129. doi: 10.1148/radiol.2016161124. Epub 2016 Oct 26.
4
Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.使用多参数3特斯拉磁共振成像和融合活检检测前列腺癌:初步结果。
Int Braz J Urol. 2016 Sep-Oct;42(5):897-905. doi: 10.1590/S1677-5538.IBJU.2015.0204.
5
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.前列腺磁共振成像和磁共振成像靶向活检在先前阴性活检患者中的应用:AUA 和 SAR 的共识声明。
J Urol. 2016 Dec;196(6):1613-1618. doi: 10.1016/j.juro.2016.06.079. Epub 2016 Jun 16.
6
Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.PI-RADS v2 词典的观察者间可重复性:六位经验丰富的前列腺放射科医生的多中心研究
Radiology. 2016 Sep;280(3):793-804. doi: 10.1148/radiol.2016152542. Epub 2016 Apr 1.
7
A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.一项评价磁共振成像在普通人群中前列腺癌筛查作用的初步研究。
J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.
8
Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.前列腺癌:多参数磁共振成像中采用修订版前列腺影像报告和数据系统时的观察者间一致性及准确性
Radiology. 2015 Dec;277(3):741-50. doi: 10.1148/radiol.2015142818. Epub 2015 Jun 18.
9
Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.通过前列腺扩散加权磁共振成像估计的表观扩散系数的短期可重复性。
Abdom Imaging. 2015 Oct;40(7):2523-8. doi: 10.1007/s00261-015-0396-x.
10
Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.前列腺影像报告和数据系统和李克特评分系统:多参数磁共振成像验证研究以筛查初始活检患者。
Radiology. 2015 May;275(2):458-68. doi: 10.1148/radiol.14140184. Epub 2015 Jan 19.